154 related articles for article (PubMed ID: 25690161)
21. GDF-15 negatively regulates excess erythropoiesis and its overexpression is involved in erythroid hyperplasia.
Ranjbaran R; Abbasi M; Rahimian E; Dehbidi GR; Seyyedi N; Zare F; Behzad-Behbahani A
Exp Cell Res; 2020 Dec; 397(2):112346. PubMed ID: 33164866
[TBL] [Abstract][Full Text] [Related]
22. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines.
Strelau J; Schmeer C; Peterziel H; Sackmann T; Herold-Mende C; Steiner H; Weller M; Unsicker K
Cancer Lett; 2008 Oct; 270(1):30-9. PubMed ID: 18550273
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms.
Zimmers TA; Jin X; Hsiao EC; Perez EA; Pierce RH; Chavin KD; Koniaris LG
J Surg Res; 2006 Jan; 130(1):45-51. PubMed ID: 16154591
[TBL] [Abstract][Full Text] [Related]
24. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer.
Staff AC; Bock AJ; Becker C; Kempf T; Wollert KC; Davidson B
Gynecol Oncol; 2010 Sep; 118(3):237-43. PubMed ID: 20576287
[TBL] [Abstract][Full Text] [Related]
25. GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.
Xiao QA; He Q; Zeng J; Xia X
Biomed Pharmacother; 2022 Feb; 146():112582. PubMed ID: 34959119
[TBL] [Abstract][Full Text] [Related]
26. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
[TBL] [Abstract][Full Text] [Related]
27. GDF-15 prevents platelet integrin activation and thrombus formation.
Rossaint J; Vestweber D; Zarbock A
J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
[TBL] [Abstract][Full Text] [Related]
28. Growth differentiation factor 15: A novel biomarker with high clinical potential.
Desmedt S; Desmedt V; De Vos L; Delanghe JR; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2019 Aug; 56(5):333-350. PubMed ID: 31076013
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.
Zimmers TA; Jin X; Hsiao EC; McGrath SA; Esquela AF; Koniaris LG
Shock; 2005 Jun; 23(6):543-8. PubMed ID: 15897808
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells.
Lee J; Fricke F; Warnken U; Schnölzer M; Kopitz J; Gebert J
PLoS One; 2015; 10(6):e0131506. PubMed ID: 26114631
[TBL] [Abstract][Full Text] [Related]
31. Growth Differentiation Factor-15 Orchestrates Inflammation-Related Diseases via Macrophage Polarization.
Huang J; Ding X; Dong Y; Zhu H
Discov Med; 2024 Feb; 36(181):248-255. PubMed ID: 38409830
[TBL] [Abstract][Full Text] [Related]
32. Macrophage inhibitory cytokine-1: a new player in melanoma development.
Yamashita T; Yoneta A; Hida T
J Invest Dermatol; 2009 Feb; 129(2):262-4. PubMed ID: 19148214
[TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy.
Tantawy AA; Adly AA; Ismail EA; Youssef OI; Ali ME
Blood Cells Mol Dis; 2015 Aug; 55(2):144-50. PubMed ID: 26142330
[TBL] [Abstract][Full Text] [Related]
34. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
35. GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin.
Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Chen Y; Routy JP
Front Endocrinol (Lausanne); 2020; 11():581839. PubMed ID: 33312159
[TBL] [Abstract][Full Text] [Related]
36. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.
Xu X; Li Z; Gao W
Biomarkers; 2011 Sep; 16(6):466-75. PubMed ID: 21718220
[TBL] [Abstract][Full Text] [Related]
37. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
Lind L; Wallentin L; Kempf T; Tapken H; Quint A; Lindahl B; Olofsson S; Venge P; Larsson A; Hulthe J; Elmgren A; Wollert KC
Eur Heart J; 2009 Oct; 30(19):2346-53. PubMed ID: 19561023
[TBL] [Abstract][Full Text] [Related]
38. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
39. GDF-15/MIC-1 a novel member of the TGF-beta superfamily.
Strelau J; Böttner M; Lingor P; Suter-Crazzolara C; Galter D; Jaszai J; Sullivan A; Schober A; Krieglstein K; Unsicker K
J Neural Transm Suppl; 2000; (60):273-6. PubMed ID: 11205146
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.
Banaszkiewicz M; Małyszko J; Batko K; Koc-Żórawska E; Żórawski M; Dumnicka P; Jurczyszyn A; Woziwodzka K; Tisończyk J; Krzanowski M; Małyszko J; Waszczuk-Gajda A; Drożdż R; Kuźniewski M; Krzanowska K
Mediators Inflamm; 2020; 2020():5657864. PubMed ID: 33144847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
